Difficulty: Medium
Average Score: 82%
Practice
Which intervention is most appropriate for a neonate with hyperbilirubinemia at risk of kernicterus?
Correct answer
C
Rationale
In the case of a neonate with hyperbilirubinemia at risk of kernicterus, the most appropriate intervention is phototherapy (Option C). Phototherapy is the standard treatment for neonatal hyperbilirubinemia as it helps to convert unconjugated bilirubin into a water-soluble form that can be excreted by the infant. This reduces the bilirubin levels in the blood, preventing the potential neurological damage associated with kernicterus.
Option A, exchange transfusion, is a more invasive procedure reserved for severe cases of hyperbilirubinemia that do not respond to phototherapy. It involves replacing the infant's blood with donor blood to rapidly decrease bilirubin levels.
Option B, intravenous fluids, would not directly address the issue of hyperbilirubinemia and kernicterus. While hydration is important in neonates, it is not the primary treatment for this condition.
Option D, oral phenobarbital, is not indicated for the treatment of hyperbilirubinemia in neonates. Phenobarbital is sometimes used in older children with certain types of seizures but is not a first-line treatment for neonatal jaundice.
In an educational context, understanding the appropriate interventions for neonatal hyperbilirubinemia is crucial for pediatric nurses. By knowing the rationale behind each treatment option, nurses can provide safe and effective care to neonates at risk of kernicterus, ensuring positive outcomes for these vulnerable patients.
Option A, exchange transfusion, is a more invasive procedure reserved for severe cases of hyperbilirubinemia that do not respond to phototherapy. It involves replacing the infant's blood with donor blood to rapidly decrease bilirubin levels.
Option B, intravenous fluids, would not directly address the issue of hyperbilirubinemia and kernicterus. While hydration is important in neonates, it is not the primary treatment for this condition.
Option D, oral phenobarbital, is not indicated for the treatment of hyperbilirubinemia in neonates. Phenobarbital is sometimes used in older children with certain types of seizures but is not a first-line treatment for neonatal jaundice.
In an educational context, understanding the appropriate interventions for neonatal hyperbilirubinemia is crucial for pediatric nurses. By knowing the rationale behind each treatment option, nurses can provide safe and effective care to neonates at risk of kernicterus, ensuring positive outcomes for these vulnerable patients.